DCF — SOUTHEASTHEALTH CENTER OF STODDARD C
Enterprise Value: $-86.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-86.4M
Enterprise Value
$-26.8M
PV of Cash Flows
$-59.7M
PV of Terminal Value
$-96.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $37.2M | $-5.7M | -15.0% | $-7.3M | $-6.6M |
| Year 2 | $38.3M | $-5.5M | -14.0% | $-7.1M | $-5.9M |
| Year 3 | $39.4M | $-5.3M | -13.0% | $-6.9M | $-5.2M |
| Year 4 | $40.6M | $-5.2M | -13.0% | $-6.9M | $-4.7M |
| Year 5 | $41.8M | $-5.3M | -13.0% | $-7.0M | $-4.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-86.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$36.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1582011212092027
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5